SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-054865
Filing Date
2023-10-24
Accepted
2023-10-24 16:18:09
Documents
5
Period of Report
2023-10-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A srzn_2023_def_14a_sm.htm DEF 14A 442912
2 GRAPHIC img201395689_0.jpg GRAPHIC 22339
3 GRAPHIC img201395689_1.jpg GRAPHIC 22339
4 GRAPHIC img201395689_2.jpg GRAPHIC 190303
5 GRAPHIC img201395689_3.jpg GRAPHIC 278440
  Complete submission text file 0000950170-23-054865.txt   1151546
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39635 | Film No.: 231342886
SIC: 2836 Biological Products, (No Diagnostic Substances)